drugset / Trial / NCT01757106

Xenon in Off-pump Coronary Artery Bypass Graft Surgery

NCT01757106

Phase 2 Completed 42 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedParallel-groupDouble-blindTreatment

Summary

Purpose of this study is to test whether xenon application during off-pump-coronary artery bypass (OPCAB)-surgery is safe and feasible.

Timeline

Start
2012-12
Primary completion
2013-07
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sevoflurane Other / unclassified 1.4 % Inhaled
Subject Xenon Other / unclassified 50 % Inhaled
Subject Xenon Other / unclassified 60 % Inhaled